Mechanisms of self-renewal in human embryonic stem cells.

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Rebecca StewartMajlinda Lako

Abstract

Embryonic stem cells (ESCs) are the pluripotent cell population derived from the inner cell mass of pre-implantation embryos and are characterised by prolonged self-renewal and the potential to differentiate into cells representing all three germ layers both in vitro and in vivo. Preservation of the undifferentiated status of the ESC population requires the maintenance of self-renewal whilst inhibiting differentiation and regulating senescence and apoptosis. In this review, we discuss the intrinsic and extrinsic factors associated with self-renewal process, together with possible signalling pathway interactions and mechanisms of regulation.

References

Nov 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·D Solter, B B Knowles
Jul 1, 1992·Experimental Gerontology·W E Wright, J W Shay
Jan 1, 1992·Advances in Cancer Research·C Basilico, D Moscatelli
Mar 1, 1991·Mutation Research·C B Harley
Oct 1, 1991·Trends in Genetics : TIG·H R Schöler
Nov 30, 1990·Biochemical and Biophysical Research Communications·M HashimotoM Muramatsu
Oct 18, 1972·Nature: New Biology·J D Watson
Dec 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·E G BerstineB Ephrussi
Dec 1, 1966·Journal of Reproduction and Fertility·K Yoshinaga, C E Adams
Oct 1, 1966·Journal of Reproduction and Fertility·S J Mantalenakis, M M Ketchel
Dec 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G R Martin
May 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M YoshidaT Beppu
Oct 1, 1994·Mammalian Genome : Official Journal of the International Mammalian Genome Society·M StevanovicP Goodfellow
Sep 27, 1994·Proceedings of the National Academy of Sciences of the United States of America·H HondermarckR A Bradshaw
Jan 1, 1993·Advances in Cancer Research·D E Johnson, L T Williams
Nov 1, 1995·Developmental Dynamics : an Official Publication of the American Association of Anatomists·F BeckR James
May 1, 1996·Genes & Development·L J Ko, C Prives
Jul 1, 1997·The EMBO Journal·H AberleR Kemler
May 1, 1997·The International Journal of Biochemistry & Cell Biology·A R GendallM Ernst
Apr 16, 1998·Current Biology : CB·T L BeattieL Harrington
Nov 6, 1998·Science·J A ThomsonJ M Jones

❮ Previous
Next ❯

Citations

Nov 16, 2007·Cell and Tissue Research·Stuart Atkinson, Lyle Armstrong
Sep 20, 2007·Science in China. Series C, Life Sciences·YuXiao LiuXueTao Pei
Sep 16, 2010·Nature Communications·Andrea WalkerNoboru Sato
Feb 7, 2007·The Journal of Experimental Medicine·Atta BehfarAndre Terzic
Apr 30, 2009·Stem Cells and Development·Yuan GaoJianwu Dai
Jan 30, 2010·Journal of Lipid Research·Min Young LeeHo Jae Han
May 6, 2014·Stem Cell Research·Sung-Hyun KimZigang Dong
Feb 24, 2016·International Journal of Molecular Sciences·Chenxia HuLanjuan Li
Sep 15, 2009·Biochimica Et Biophysica Acta·Chien-Tsun ChenYau-Huei Wei
Jul 22, 2008·Biomaterials·Norhayati Siti-IsmailAthanasios Mantalaris
Jun 13, 2009·Stem Cells·Ken Kwok-Keung ChanAndre Boon-Hwa Choo
Oct 20, 2006·Theriogenology·Kevin D Sinclair, Ravinder Singh
Mar 21, 2017·Journal of Cellular Biochemistry·Abdolreza Ardeshirylajimi
Jun 18, 2017·Molecular Neurobiology·Ashwathnarayan AshwiniAnujith Kumar
Aug 21, 2020·BMC Cancer·Selma ZargariMohammad Mahdi Forghanifard

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Fate Conversion By mRNA

mRNA-based technology is being studied as a potential technology that could be used to reprogram cell fate. This technique provides the potential to generate safe reprogrammed cells that can be used for clinical applications. Here is the latest research on cell fate conversion by mRNA.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Satoshi Nishizuka
Current Opinion in Genetics & Development
Fiona M WattVioleta Silva-Vargas
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Anne T Collins, Norman J Maitland
© 2022 Meta ULC. All rights reserved